Cite
Bentur OS, Li J, Jiang CS, et al. Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist. TH Open. 2021;5(3):e449-e460doi: 10.1055/s-0041-1732343.
Bentur, O. S., Li, J., Jiang, C. S., Martin, L. H., Kereiakes, D. J., & Coller, B. S. (2021). Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist. TH open : companion journal to thrombosis and haemostasis, 5(3), e449-e460. https://doi.org/10.1055/s-0041-1732343
Bentur, Ohad S, et al. "Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist." TH open : companion journal to thrombosis and haemostasis vol. 5,3 (2021): e449-e460. doi: https://doi.org/10.1055/s-0041-1732343
Bentur OS, Li J, Jiang CS, Martin LH, Kereiakes DJ, Coller BS. Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist. TH Open. 2021 Sep 28;5(3):e449-e460. doi: 10.1055/s-0041-1732343. eCollection 2021 Jul. PMID: 34604694; PMCID: PMC8478527.
Copy
Download .nbib
